While the exact mechanisms by which IGFBP7 influences tumour progression and treatment response are complex and context‐dependent, emerging evidence suggests that it plays a multifaceted role in cancer development, progression and immunotherapy [29, 30]. The gene discussed is IGFBP7; the disease is neoplasm.